Medication "Vestiibo". Instructions for use
Vestibo tablets are contained in betagistinedihydrochloride. The drug has a histamine-like, vasodolating effect. Medication due to direct agonistic action on H1 receptors in the inner ear and sphincter vessels (precapillary) microcirculatory bed and mediated influence on H3 receptors promotes improvement of permeability and microcirculation in the capillary system, stabilization of endolymph pressure in the cochlea and labyrinth, increase of blood flow in the basilar artery. The drug eliminates the disorders of both the cochlear and vestibular apparatus. In particular, the drug helps to reduce the intensity and frequency of dizziness, noise in the ears, improve the auditory function when it is disturbed. The drug does not have sedative activity, it does not provoke drowsiness. The drug is rapidly absorbed. With plasma proteins, the drug is not practically bound.
Means of "Vestiibo". Indications for use. Price
The medicine is prescribed for labyrinthine andvestibular disorders. In particular, the medication is effective for noise or pain in the ears, dizziness, vomiting, nausea, headache, hearing loss. The drug Vestibo recommends using the labyrinthite, vestibular neuritis, positional dizziness of a benign type (after neurosurgical interventions, including), with Ménière syndrome, edema of the labyrinth in the inner ear. As part of the combined effect of the drug is prescribed for encephalopathy (post-traumatic), vertebrobasilar insufficiency, atherosclerotic lesions in the vessels of the brain. The cost of the medicine is from 120 r.
Contraindications
The medication "Vestiobo" is not prescribed (instructionon application warns about it) with pheochromocytoma, hypersensitivity, bronchial asthma. Contraindications include pregnancy, ulcerative lesions in the duodenum and stomach (exacerbation). Caution is shown in the treatment of patients in childhood. Dose adjustment is necessary if there is anamnestic data on peptic ulcer in the digestive tract. The expediency of appointment in the second and third trimester of the prenatal period is determined by the doctor.
Side effects
To the negative consequences of therapy with Vestibo medication, the instructions for use include Quincke's edema, dyspepsia, skin rash.
Dosing regimen
Drug is drunk with food. Drink recommended liquid in a small amount. The drug "Vestiibo" instructions for use recommends taking a long period. Means with a dosage of 8 and 16 mg prescribed for 1-2 tab. Frequency of reception - 2-4 r / d. The drug with a dosage of 24 mg take 0.5-1 tab twice a day. The maximum allowable amount of medication per day is 48 mg.
additional information
In some cases, the therapeutic outcomeis noted only after several months of admission. In case of an overdose, side reactions increase, tachycardia develops, pressure decreases, bronchospasm is likely. Recommended treatment in accordance with the symptoms.
